+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
RNA Synthesis Market by Product Type (Messenger Rna, Micro Rna, Single Guide Rna), Technology (Chemical Synthesis, Enzymatic Synthesis), Application, Scale, End User - Global Forecast 2025-2030- Product Image
RNA Synthesis Market by Product Type (Messenger Rna, Micro Rna, Single Guide Rna), Technology (Chemical Synthesis, Enzymatic Synthesis), Application, Scale, End User - Global Forecast 2025-2030- Product Image
Sale

RNA Synthesis Market by Product Type (Messenger Rna, Micro Rna, Single Guide Rna), Technology (Chemical Synthesis, Enzymatic Synthesis), Application, Scale, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 199 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6122981
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The RNA synthesis market is undergoing a period of rapid evolution driven by breakthroughs in molecular engineering and a surge of interest from both public and private research sectors. Recent advancements in precision transcription methods have fundamentally altered how synthetic RNA is produced at scale, enabling scientists to pursue novel therapeutic modalities with unmatched specificity. At the same time, the acceleration of vaccine development platforms during global health emergencies has underscored the importance of robust supply chains and flexible manufacturing capabilities.

In this context, stakeholders ranging from academic laboratories to large biopharmaceutical enterprises seek to navigate an increasingly complex ecosystem. Emerging challenges such as reagent cost fluctuations and raw material sourcing constraints are juxtaposed against opportunities created by next-generation sequencing integration and computational design tools. Moreover, collaborative alliances between technology providers and end users are fostering a new era of co-development and shared intellectual property frameworks that promise to streamline innovation pipelines and reduce time to clinic.

Emerging Technological Breakthroughs and Strategic Collaborations Driving Unprecedented Transformation in RNA Synthesis Landscape

Over the past few years, a convergence of technological breakthroughs and strategic partnerships has reshaped the RNA synthesis landscape in profound ways. Innovations in enzymatic transcription have enabled higher purity products with fewer byproducts, reducing downstream purification burdens. Concurrently, the refinement of solid-phase phosphoramidite methods has improved throughput and yield, making longer RNA constructs economically viable for complex therapeutic applications.

In parallel, cross-sector collaborations are driving integrated platforms that merge automated synthesis with real-time quality control analytics. These alliances span contract research organizations, instrument manufacturers, and oligonucleotide providers, fostering an ecosystem where continuous feedback loops accelerate process optimization. Regulatory agencies have also embraced adaptive frameworks, expediting the review of novel RNA-based modalities and encouraging investment in scalable manufacturing solutions. As a result, organizations are rapidly transforming conceptual RNA designs into clinically relevant candidates, marking a new chapter in precision medicine.

Assessing the Cumulative Impact of United States Tariff Policies Introduced in 2025 on the RNA Synthesis Supply Chain and Cost Structures

In 2025, newly implemented United States tariff policies on critical raw materials and reagents have introduced additional complexity to the RNA synthesis value chain. Increased duties on imported phosphoramidite precursors and specialized enzyme components have translated into higher input costs for manufacturers and researchers alike. Consequently, many organizations are reassessing supplier networks and seeking regionalized sourcing strategies to mitigate exposure to fluctuating trade measures.

Yet, these challenges have also spurred innovation in reagent recycling and alternative synthesis pathways. Several forward-thinking entities have accelerated efforts to repurpose byproducts and implement closed-loop manufacturing systems that reduce dependency on tariff-affected imports. Moreover, nearshoring initiatives in North America are gaining momentum as companies strive to fortify resilience against future policy shifts. This reconfiguration of the supply chain underscores the importance of agility and collaborative procurement agreements in maintaining uninterrupted production schedules.

Detailed Segmentation Insights Revealing How Product Type Technology Application Scale and End User Preferences Shape the RNA Synthesis Market

The segmentation of the RNA synthesis market reveals nuanced dynamics that inform strategy at every stage of development. By product type, the industry encompasses messenger RNA, which has gained prominence through vaccine applications; micro RNA, an emerging target for regulatory therapeutics; single guide RNA, integral to gene editing platforms; small interfering RNA, a cornerstone of gene silencing studies; and transfer RNA, a critical component in translational research. Each of these categories presents distinct technical requirements and end-user expectations, shaping demand and innovation priorities.

Turning to technology, chemical synthesis approaches are characterized by liquid phase processing, which offers flexibility for bespoke sequences, and solid phase phosphoramidite methods, which deliver enhanced efficiency for routine oligonucleotide production. Enzymatic synthesis further differentiates itself through in vitro transcription techniques, which enable rapid generation of long RNA strands, and rolling circle transcription methods, which yield repetitive constructs at scale. These technological pathways are being selected based on factors such as sequence length, purity requirements, and cost constraints.

Applications of synthetic RNA span diagnostics, where clinical diagnostics platforms demand high-fidelity probes while point-of-care formats prioritize rapid turnaround; research domains, where basic research benefits from standardized library synthesis and drug discovery initiatives rely on customized RNA constructs; therapeutics, with a focus on genetic disorders, infectious diseases, and oncology, each driving specific delivery and modification strategies; and vaccines, encompassing rapid response formulations designed for emerging pathogens alongside seasonal vaccines requiring streamlined manufacturing cycles. Within each application, performance characteristics, regulatory considerations, and time to deployment guide technology choice and investment.

Analysis by scale highlights the dichotomy between commercial operations and laboratory activities. Bulk manufacturing and GMP production facilities underpin large-volume supply chains for established therapeutic and vaccine programs, whereas prototyping and R&D uses demand lower volumes with greater flexibility for iterative design. Finally, end users range from academic institutions pushing the frontiers of fundamental science to biotechnology companies translating molecular discoveries into clinical candidates, contract research organizations offering specialized synthesis services, and pharmaceutical companies integrating RNA constructs into broader therapeutic portfolios. Together, these segments define a multifaceted market in which strategic alignment with customer needs and technical capabilities determines success.

Comprehensive Regional Analysis Highlighting Distinctive Trends and Growth Drivers Across Americas Europe Middle East Africa and Asia Pacific

Regional dynamics within the RNA synthesis sector vary significantly as stakeholders adapt to unique market conditions. In the Americas, the presence of leading research universities and established contract development and manufacturing hubs has created a robust environment for both early-stage discovery and large-scale production. Strong regulatory frameworks, extensive venture capital networks, and government incentives further position this region as a critical innovator in high-value RNA technologies.

Across Europe, the Middle East & Africa, diverse regulatory landscapes and investment climates are influencing adoption rates and application focus areas. In Western Europe, collaborative research initiatives and harmonized market regulations are driving growth in precision diagnostics and therapeutic platforms. In parallel, emerging economies in the Middle East and Africa are increasing funding for biotechnology infrastructure, creating new opportunities for partnerships centered on local manufacturing and capacity building. Meanwhile, Asia-Pacific is witnessing accelerated expansion driven by cost-efficient manufacturing, strategic government subsidies, and growing domestic demand. Major markets in China, India, Japan, and South Korea are bolstering capabilities in enzyme production, automated synthesis platforms, and integrated quality control systems to serve both regional and global customers.

Critical Company Profiles and Competitive Strategies Shaping Leadership Dynamics in the Global RNA Synthesis Industry Landscape

Leading organizations in the RNA synthesis industry are distinguished by their ability to integrate end-to-end solutions, from custom sequence design to large-scale manufacturing and regulatory support. Some global leaders have invested heavily in modular platforms that combine automated synthesis hardware with advanced purification workflows, ensuring consistent product quality across diverse molecular targets. Others have established strategic partnerships with academic centers and biotechnology innovators to co-develop proprietary enzyme formulations that enhance transcription fidelity.

In addition to in-house technological advancements, competitive strategies often involve targeted mergers and acquisitions aimed at expanding service portfolios or entering high-growth application segments. These transactions frequently focus on acquiring specialized contract research operations or nucleic acid manufacturing facilities in emerging markets to diversify geographic presence. As a result, robust distribution networks and comprehensive service offerings are becoming key differentiators in a landscape where customers prioritize seamless integration of design, synthesis, and quality assurance processes.

Strategic Actionable Recommendations Empowering Industry Leaders to Capitalize on Emerging Opportunities in RNA Synthesis

Industry leaders seeking to capitalize on emerging RNA synthesis opportunities should prioritize investments in next-generation enzymatic platforms that offer superior throughput and environmental benefits compared to traditional chemical methods. By adopting continuous manufacturing principles and closed-loop quality systems, organizations can minimize reagent waste and accelerate time to market. It is equally important to establish flexible supply agreements with multiple reagent providers to mitigate the impact of trade policy changes and raw material shortages.

Furthermore, forging collaborative alliances with academic institutions and technology innovators can unlock access to cutting-edge modifications and delivery chemistries, enabling the rapid translation of laboratory breakthroughs into clinical assets. Proactive engagement with regulatory authorities to define clear pathways for novel RNA modalities will also reduce approval timelines and enhance commercial uptake. Finally, expanding footprint in high-growth regions through joint ventures or local partnerships can secure strategic positioning in markets that are rapidly scaling their biotechnology infrastructure.

Rigorous Research Methodology Detailing Primary Secondary Qualitative and Quantitative Approaches Underpinning the RNA Synthesis Study

This research framework was constructed using a rigorous blend of primary and secondary research methodologies. Expert interviews with senior executives, scientific directors, and process engineers provided qualitative insights into emerging trends, technological challenges, and strategic priorities. These conversations were complemented by structured surveys of end users to validate demand drivers and identify regional adoption patterns.

Secondary research incorporated a comprehensive review of peer-reviewed publications, patent filings, regulatory guidance documents, and technology white papers to ensure a deep understanding of synthesis methodologies and application requirements. Data triangulation techniques were employed to cross-verify information from multiple sources, while quantitative analysis focused on historical adoption rates of various synthesis technologies and shifts in supply chain configurations. The result is a robust, transparent methodology that underpins the conclusions and recommendations presented throughout this report.

Conclusive Overview Recapping Key Insights and Future Imperatives for Stakeholders in the RNA Synthesis Ecosystem

Throughout this executive summary, we have explored the dynamic forces reshaping the RNA synthesis arena, from groundbreaking technological innovations and collaborative ecosystems to the strategic ramifications of evolving trade policies. The segmentation analysis underscores the multifaceted nature of demand across product types, synthesis technologies, application domains, production scales, and end-user groups. Regional insights reveal distinct market drivers and regulatory landscapes that influence strategic decision-making on a global scale.

Key company profiles illustrate how competitive positioning hinges on integrated service offerings, strategic partnerships, and targeted investments in high-value capabilities. Actionable recommendations emphasize the importance of supply chain resilience, regulatory engagement, and market expansion strategies. By synthesizing these insights, industry stakeholders can chart a clear path toward sustained growth, operational excellence, and innovation leadership within the rapidly maturing RNA synthesis ecosystem.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product Type
    • Messenger Rna
    • Micro Rna
    • Single Guide Rna
    • Small Interfering Rna
    • Transfer Rna
  • Technology
    • Chemical Synthesis
      • Liquid Phase
      • Solid Phase Phosphoramidite
    • Enzymatic Synthesis
      • In Vitro Transcription
      • Rolling Circle Transcription
  • Application
    • Diagnostics
      • Clinical Diagnostics
      • Point Of Care Diagnostics
    • Research
      • Basic Research
      • Drug Discovery
    • Therapeutics
      • Genetic Disorders
      • Infectious Diseases
      • Oncology
    • Vaccines
      • Rapid Response Vaccines
      • Seasonal Vaccines
  • Scale
    • Commercial Scale
      • Bulk Manufacturing
      • Gmp Production
    • Laboratory Scale
      • Prototyping
      • Rd Use
  • End User
    • Academic Institutions
    • Biotechnology Companies
    • Contract Research Organizations
    • Pharmaceutical Companies
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Danaher Corporation
  • Agilent Technologies, Inc.
  • Eurofins Scientific SE
  • Azenta, Inc.
  • GenScript Biotech Corporation
  • Bio-Rad Laboratories, Inc.
  • QIAGEN N.V.
  • PerkinElmer, Inc.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Adoption of cell-free enzymatic synthesis platforms for scalable RNA fragment production
5.2. Integration of real-time quality control analytics in automated RNA oligonucleotide synthesis workflows
5.3. Development of novel capping reagents to improve mRNA stability and translation efficiency
5.4. Emergence of sustainable solid-phase synthesis resins reducing solvent consumption and environmental impact
5.5. Optimizing high-fidelity polymerase enzymes for error-free long-strand RNA synthesis applications
5.6. Increased adoption of miniaturized microfluidic platforms for parallel RNA synthesis screening
5.7. Expansion of integrated long-read sequencing verification in RNA vaccine manufacturing processes
5.8. Use of AI-driven predictive modeling to enhance yield and purity of synthesized RNA strands
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. RNA Synthesis Market, by Product Type
8.1. Introduction
8.2. Messenger Rna
8.3. Micro Rna
8.4. Single Guide Rna
8.5. Small Interfering Rna
8.6. Transfer Rna
9. RNA Synthesis Market, by Technology
9.1. Introduction
9.2. Chemical Synthesis
9.2.1. Liquid Phase
9.2.2. Solid Phase Phosphoramidite
9.3. Enzymatic Synthesis
9.3.1. In Vitro Transcription
9.3.2. Rolling Circle Transcription
10. RNA Synthesis Market, by Application
10.1. Introduction
10.2. Diagnostics
10.2.1. Clinical Diagnostics
10.2.2. Point of Care Diagnostics
10.3. Research
10.3.1. Basic Research
10.3.2. Drug Discovery
10.4. Therapeutics
10.4.1. Genetic Disorders
10.4.2. Infectious Diseases
10.4.3. Oncology
10.5. Vaccines
10.5.1. Rapid Response Vaccines
10.5.2. Seasonal Vaccines
11. RNA Synthesis Market, by Scale
11.1. Introduction
11.2. Commercial Scale
11.2.1. Bulk Manufacturing
11.2.2. Gmp Production
11.3. Laboratory Scale
11.3.1. Prototyping
11.3.2. Rd Use
12. RNA Synthesis Market, by End User
12.1. Introduction
12.2. Academic Institutions
12.3. Biotechnology Companies
12.4. Contract Research Organizations
12.5. Pharmaceutical Companies
13. Americas RNA Synthesis Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa RNA Synthesis Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific RNA Synthesis Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Thermo Fisher Scientific Inc.
16.3.2. Merck KGaA
16.3.3. Danaher Corporation
16.3.4. Agilent Technologies, Inc.
16.3.5. Eurofins Scientific SE
16.3.6. Azenta, Inc.
16.3.7. GenScript Biotech Corporation
16.3.8. Bio-Rad Laboratories, Inc.
16.3.9. QIAGEN N.V.
16.3.10. PerkinElmer, Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. RNA SYNTHESIS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL RNA SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL RNA SYNTHESIS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL RNA SYNTHESIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL RNA SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL RNA SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL RNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL RNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL RNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL RNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL RNA SYNTHESIS MARKET SIZE, BY SCALE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL RNA SYNTHESIS MARKET SIZE, BY SCALE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL RNA SYNTHESIS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL RNA SYNTHESIS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS RNA SYNTHESIS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS RNA SYNTHESIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES RNA SYNTHESIS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES RNA SYNTHESIS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA RNA SYNTHESIS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA RNA SYNTHESIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC RNA SYNTHESIS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC RNA SYNTHESIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. RNA SYNTHESIS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. RNA SYNTHESIS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. RNA SYNTHESIS MARKET: RESEARCHAI
FIGURE 26. RNA SYNTHESIS MARKET: RESEARCHSTATISTICS
FIGURE 27. RNA SYNTHESIS MARKET: RESEARCHCONTACTS
FIGURE 28. RNA SYNTHESIS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. RNA SYNTHESIS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL RNA SYNTHESIS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL RNA SYNTHESIS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL RNA SYNTHESIS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL RNA SYNTHESIS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL RNA SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL RNA SYNTHESIS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL RNA SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL RNA SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL RNA SYNTHESIS MARKET SIZE, BY MESSENGER RNA, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL RNA SYNTHESIS MARKET SIZE, BY MESSENGER RNA, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL RNA SYNTHESIS MARKET SIZE, BY MICRO RNA, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL RNA SYNTHESIS MARKET SIZE, BY MICRO RNA, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL RNA SYNTHESIS MARKET SIZE, BY SINGLE GUIDE RNA, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL RNA SYNTHESIS MARKET SIZE, BY SINGLE GUIDE RNA, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL RNA SYNTHESIS MARKET SIZE, BY SMALL INTERFERING RNA, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL RNA SYNTHESIS MARKET SIZE, BY SMALL INTERFERING RNA, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL RNA SYNTHESIS MARKET SIZE, BY TRANSFER RNA, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL RNA SYNTHESIS MARKET SIZE, BY TRANSFER RNA, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL RNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL RNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL RNA SYNTHESIS MARKET SIZE, BY CHEMICAL SYNTHESIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL RNA SYNTHESIS MARKET SIZE, BY CHEMICAL SYNTHESIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL RNA SYNTHESIS MARKET SIZE, BY LIQUID PHASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL RNA SYNTHESIS MARKET SIZE, BY LIQUID PHASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL RNA SYNTHESIS MARKET SIZE, BY SOLID PHASE PHOSPHORAMIDITE, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL RNA SYNTHESIS MARKET SIZE, BY SOLID PHASE PHOSPHORAMIDITE, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL RNA SYNTHESIS MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL RNA SYNTHESIS MARKET SIZE, BY CHEMICAL SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL RNA SYNTHESIS MARKET SIZE, BY ENZYMATIC SYNTHESIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL RNA SYNTHESIS MARKET SIZE, BY ENZYMATIC SYNTHESIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL RNA SYNTHESIS MARKET SIZE, BY IN VITRO TRANSCRIPTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL RNA SYNTHESIS MARKET SIZE, BY IN VITRO TRANSCRIPTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL RNA SYNTHESIS MARKET SIZE, BY ROLLING CIRCLE TRANSCRIPTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL RNA SYNTHESIS MARKET SIZE, BY ROLLING CIRCLE TRANSCRIPTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL RNA SYNTHESIS MARKET SIZE, BY ENZYMATIC SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL RNA SYNTHESIS MARKET SIZE, BY ENZYMATIC SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL RNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL RNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL RNA SYNTHESIS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL RNA SYNTHESIS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL RNA SYNTHESIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL RNA SYNTHESIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL RNA SYNTHESIS MARKET SIZE, BY POINT OF CARE DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL RNA SYNTHESIS MARKET SIZE, BY POINT OF CARE DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL RNA SYNTHESIS MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL RNA SYNTHESIS MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL RNA SYNTHESIS MARKET SIZE, BY RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL RNA SYNTHESIS MARKET SIZE, BY RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL RNA SYNTHESIS MARKET SIZE, BY BASIC RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL RNA SYNTHESIS MARKET SIZE, BY BASIC RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL RNA SYNTHESIS MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL RNA SYNTHESIS MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL RNA SYNTHESIS MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL RNA SYNTHESIS MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL RNA SYNTHESIS MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL RNA SYNTHESIS MARKET SIZE, BY THERAPEUTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL RNA SYNTHESIS MARKET SIZE, BY GENETIC DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL RNA SYNTHESIS MARKET SIZE, BY GENETIC DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL RNA SYNTHESIS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL RNA SYNTHESIS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL RNA SYNTHESIS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL RNA SYNTHESIS MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL RNA SYNTHESIS MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL RNA SYNTHESIS MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL RNA SYNTHESIS MARKET SIZE, BY VACCINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL RNA SYNTHESIS MARKET SIZE, BY VACCINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL RNA SYNTHESIS MARKET SIZE, BY RAPID RESPONSE VACCINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL RNA SYNTHESIS MARKET SIZE, BY RAPID RESPONSE VACCINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL RNA SYNTHESIS MARKET SIZE, BY SEASONAL VACCINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL RNA SYNTHESIS MARKET SIZE, BY SEASONAL VACCINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL RNA SYNTHESIS MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL RNA SYNTHESIS MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL RNA SYNTHESIS MARKET SIZE, BY SCALE, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL RNA SYNTHESIS MARKET SIZE, BY SCALE, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL RNA SYNTHESIS MARKET SIZE, BY COMMERCIAL SCALE, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL RNA SYNTHESIS MARKET SIZE, BY COMMERCIAL SCALE, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL RNA SYNTHESIS MARKET SIZE, BY BULK MANUFACTURING, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL RNA SYNTHESIS MARKET SIZE, BY BULK MANUFACTURING, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL RNA SYNTHESIS MARKET SIZE, BY GMP PRODUCTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL RNA SYNTHESIS MARKET SIZE, BY GMP PRODUCTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL RNA SYNTHESIS MARKET SIZE, BY COMMERCIAL SCALE, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL RNA SYNTHESIS MARKET SIZE, BY COMMERCIAL SCALE, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL RNA SYNTHESIS MARKET SIZE, BY LABORATORY SCALE, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL RNA SYNTHESIS MARKET SIZE, BY LABORATORY SCALE, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL RNA SYNTHESIS MARKET SIZE, BY PROTOTYPING, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL RNA SYNTHESIS MARKET SIZE, BY PROTOTYPING, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL RNA SYNTHESIS MARKET SIZE, BY RD USE, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL RNA SYNTHESIS MARKET SIZE, BY RD USE, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL RNA SYNTHESIS MARKET SIZE, BY LABORATORY SCALE, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL RNA SYNTHESIS MARKET SIZE, BY LABORATORY SCALE, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL RNA SYNTHESIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL RNA SYNTHESIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL RNA SYNTHESIS MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL RNA SYNTHESIS MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL RNA SYNTHESIS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL RNA SYNTHESIS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL RNA SYNTHESIS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL RNA SYNTHESIS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL RNA SYNTHESIS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL RNA SYNTHESIS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS RNA SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS RNA SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS RNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS RNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS RNA SYNTHESIS MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS RNA SYNTHESIS MARKET SIZE, BY CHEMICAL SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS RNA SYNTHESIS MARKET SIZE, BY ENZYMATIC SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS RNA SYNTHESIS MARKET SIZE, BY ENZYMATIC SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS RNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS RNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS RNA SYNTHESIS MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS RNA SYNTHESIS MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS RNA SYNTHESIS MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS RNA SYNTHESIS MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS RNA SYNTHESIS MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS RNA SYNTHESIS MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS RNA SYNTHESIS MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS RNA SYNTHESIS MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS RNA SYNTHESIS MARKET SIZE, BY SCALE, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS RNA SYNTHESIS MARKET SIZE, BY SCALE, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS RNA SYNTHESIS MARKET SIZE, BY COMMERCIAL SCALE, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS RNA SYNTHESIS MARKET SIZE, BY COMMERCIAL SCALE, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS RNA SYNTHESIS MARKET SIZE, BY LABORATORY SCALE, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS RNA SYNTHESIS MARKET SIZE, BY LABORATORY SCALE, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS RNA SYNTHESIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS RNA SYNTHESIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS RNA SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS RNA SYNTHESIS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES RNA SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES RNA SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES RNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES RNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES RNA SYNTHESIS MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES RNA SYNTHESIS MARKET SIZE, BY CHEMICAL SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES RNA SYNTHESIS MARKET SIZE, BY ENZYMATIC SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES RNA SYNTHESIS MARKET SIZE, BY ENZYMATIC SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES RNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES RNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES RNA SYNTHESIS MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES RNA SYNTHESIS MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES RNA SYNTHESIS MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES RNA SYNTHESIS MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES RNA SYNTHESIS MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES RNA SYNTHESIS MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES RNA SYNTHESIS MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES RNA SYNTHESIS MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES RNA SYNTHESIS MARKET SIZE, BY SCALE, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES RNA SYNTHESIS MARKET SIZE, BY SCALE, 2025-2030 (USD MILLION)
TABLE 151. UNITED STATES RNA SYNTHESIS MARKET SIZE, BY COMMERCIAL SCALE, 2018-2024 (USD MILLION)
TABLE 152. UNITED STATES RNA SYNTHESIS MARKET SIZE, BY COMMERCIAL SCALE, 2025-2030 (USD MILLION)
TABLE 153. UNITED STATES RNA SYNTHESIS MARKET SIZE, BY LABORATORY SCALE, 2018-2024 (USD MILLION)
TABLE 154. UNITED STATES RNA SYNTHESIS MARKET SIZE, BY LABORATORY SCALE, 2025-2030 (USD MILLION)
TABLE 155. UNITED STATES RNA SYNTHESIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 156. UNITED STATES RNA SYNTHESIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 157. UNITED STATES RNA SYNTHESIS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 158. UNITED STATES RNA SYNTHESIS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 159. CANADA RNA SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 160. CANADA RNA SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 161. CANADA RNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 162. CANADA RNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 163. CANADA RNA SYNTHESIS MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 164. CANADA RNA SYNTHESIS MARKET SIZE, BY CHEMICAL SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 165. CANADA RNA SYNTHESIS MARKET SIZE, BY ENZYMATIC SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 166. CANADA RNA SYNTHESIS MARKET SIZE, BY ENZYMATIC SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 167. CANADA RNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 168. CANADA RNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 169. CANADA RNA SYNTHESIS MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 170. CANADA RNA SYNTHESIS MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 171. CANADA RNA SYNTHESIS MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 172. CANADA RNA SYNTHESIS MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 173. CANADA RNA SYNTHESIS MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 174. CANADA RNA SYNTHESIS MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 175. CANADA RNA SYNTHESIS MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 176. CANADA RNA SYNTHESIS MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 177. CANADA RNA SYNTHESIS MARKET SIZE, BY SCALE, 2018-2024 (USD MILLION)
TABLE 178. CANADA RNA SYNTHESIS MARKET SIZE, BY SCALE, 2025-2030 (USD MILLION)
TABLE 179. CANADA RNA SYNTHESIS MARKET SIZE, BY COMMERCIAL SCALE, 2018-2024 (USD MILLION)
TABLE 180. CANADA RNA SYNTHESIS MARKET SIZE, BY COMMERCIAL SCALE, 2025-2030 (USD MILLION)
TABLE 181. CANADA RNA SYNTHESIS MARKET SIZE, BY LABORATORY SCALE, 2018-2024 (USD MILLION)
TABLE 182. CANADA RNA SYNTHESIS MARKET SIZE, BY LABORATORY SCALE, 2025-2030 (USD MILLION)
TABLE 183. CANADA RNA SYNTHESIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 184. CANADA RNA SYNTHESIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 185. MEXICO RNA SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 186. MEXICO RNA SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 187. MEXICO RNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 188. MEXICO RNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 189. MEXICO RNA SYNTHESIS MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 190. MEXICO RNA SYNTHESIS MARKET SIZE, BY CHEMICAL SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 191. MEXICO RNA SYNTHESIS MARKET SIZE, BY ENZYMATIC SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 192. MEXICO RNA SYNTHESIS MARKET SIZE, BY ENZYMATIC SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 193. MEXICO RNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 194. MEXICO RNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 195. MEXICO RNA SYNTHESIS MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 196. MEXICO RNA SYNTHESIS MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 197. MEXICO RNA SYNTHESIS MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 198. MEXICO RNA SYNTHESIS MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 199. MEXICO RNA SYNTHESIS MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 200. MEXICO RNA SYNTHESIS MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 201. MEXICO RNA SYNTHESIS MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 202. MEXICO RNA SYNTHESIS MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 203. MEXICO RNA SYNTHESIS MARKET SIZE, BY SCALE, 2018-2024 (USD MILLION)
TABLE 204. MEXICO RNA SYNTHESIS MARKET SIZE, BY SCALE, 2025-2030 (USD MILLION)
TABLE 205. MEXICO RNA SYNTHESIS MARKET SIZE, BY COMMERCIAL SCALE, 2018-2024 (USD MILLION)
TABLE 206. MEXICO RNA SYNTHESIS MARKET SIZE, BY COMMERCIAL SCALE, 2025-2030 (USD MILLION)
TABLE 207. MEXICO RNA SYNTHESIS MARKET SIZE, BY LABORATORY SCALE, 2018-2024 (USD MILLION)
TABLE 208. MEXICO RNA SYNTHESIS MARKET SIZE, BY LABORATORY SCALE, 2025-2030 (USD MILLION)
TABLE 209. MEXICO RNA SYNTHESIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 210. MEXICO RNA SYNTHESIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 211. BRAZIL RNA SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 212. BRAZIL RNA SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 213. BRAZIL RNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 214. BRAZIL RNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 215. BRAZIL RNA SYNTHESIS MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 216. BRAZIL RNA SYNTHESIS MARKET SIZE, BY CHEMICAL SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 217. BRAZIL RNA SYNTHESIS MARKET SIZE, BY ENZYMATIC SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 218. BRAZIL RNA SYNTHESIS MARKET SIZE, BY ENZYMATIC SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 219. BRAZIL RNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 220. BRAZIL RNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 221. BRAZIL RNA SYNTHESIS MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 222. BRAZIL RNA SYNTHESIS MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 223. BRAZIL RNA SYNTHESIS MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 224. BRAZIL RNA SYNTHESIS MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 225. BRAZIL RNA SYNTHESIS MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 226. BRAZIL RNA SYNTHESIS MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 227. BRAZIL RNA SYNTHESIS MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 228. BRAZIL RNA SYNTHESIS MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 229. BRAZIL RNA SYNTHESIS MARKET SIZE, BY SCALE, 2018-2024 (USD MILLION)
TABLE 230. BRAZIL RNA SYNTHESIS MARKET SIZE, BY SCALE, 2025-2030 (USD MILLION)
TABLE 231. BRAZIL RNA SYNTHESIS MARKET SIZE, BY COMMERCIAL SCALE, 2018-2024 (USD MILLION)
TABLE 232. BRAZIL RNA SYNTHESIS MARKET SIZE, BY COMMERCIAL SCALE, 2025-2030 (USD MILLION)
TABLE 233. BRAZIL RNA SYNTHESIS MARKET SIZE, BY LABORATORY SCALE, 2018-2024 (USD MILLION)
TABLE 234. BRAZIL RNA SYNTHESIS MARKET SIZE, BY LABORATORY SCALE, 2025-2030 (USD MILLION)
TABLE 235. BRAZIL RNA SYNTHESIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 236. BRAZIL RNA SYNTHESIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 237. ARGENTINA RNA SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 238. ARGENTINA RNA SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 239. ARGENTINA RNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 240. ARGENTINA RNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 241. ARGENTINA RNA SYNTHESIS MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 242. ARGENTINA RNA SYNTHESIS MARKET SIZE, BY CHEMICAL SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 243. ARGENTINA RNA SYNTHESIS MARKET SIZE, BY ENZYMATIC SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 244. ARGENTINA RNA SYNTHESIS MARKET SIZE, BY ENZYMATIC SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 245. ARGENTINA RNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 246. ARGENTINA RNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 247. ARGENTINA RNA SYNTHESIS MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 248. ARGENTINA RNA SYNTHESIS MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 249. ARGENTINA RNA SYNTHESIS MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 250. ARGENTINA RNA SYNTHESIS MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 251. ARGENTINA RNA SYNTHESIS MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 252. ARGENTINA RNA SYNTHESIS MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 253. ARGENTINA RNA SYNTHESIS MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 254. ARGENTINA RNA SYNTHESIS MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 255. ARGENTINA RNA SYNTHESIS MARKET SIZE, BY SCALE, 2018-2024 (USD MILLION)
TABLE 256. ARGENTINA RNA SYNTHESIS MARKET SIZE, BY SCALE, 2025-2030 (USD MILLION)
TABLE 257. ARGENTINA RNA SYNTHESIS MARKET SIZE, BY COMMERCIAL SCALE, 2018-2024 (USD MILLION)
TABLE 258. ARGENTINA RNA SYNTHESIS MARKET SIZE, BY COMMERCIAL SCALE, 2025-2030 (USD MILLION)
TABLE 259. ARGENTINA RNA SYNTHESIS MARKET SIZE, BY LABORATORY SCALE, 2018-2024 (USD MILLION)
TABLE 260. ARGENTINA RNA SYNTHESIS MARKET SIZE, BY LABORATORY SCALE, 2025-2030 (USD MILLION)
TABLE 261. ARGENTINA RNA SYNTHESIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 262. ARGENTINA RNA SYNTHESIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 263. EUROPE, MIDDLE EAST & AFRICA RNA SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 264. EUROPE, MIDDLE EAST & AFRICA RNA SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 265. EUROPE, MIDDLE EAST & AFRICA RNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 266. EUROPE, MIDDLE EAST & AFRICA RNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 267. EUROPE, MIDDLE EAST & AFRICA RNA SYNTHESIS MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 268. EUROPE, MIDDLE EAST & AFRICA RNA SYNTHESIS MARKET SIZE, BY CHEMICAL SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 269. EUROPE, MIDDLE EAST & AFRICA RNA SYNTHESIS MARKET SIZE, BY ENZYMATIC SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 270. EUROPE, MIDDLE EAST & AFRICA RNA SYNTHESIS MARKET SIZE, BY ENZYMATIC SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 271. EUROPE, MIDDLE EAST & AFRICA RNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 272. EUROPE, MIDDLE EAST & AFRICA RNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 273. EUROPE, MIDDLE EAST & AFRICA RNA SYNTHESIS MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 274. EUROPE, MIDDLE EAST & AFRICA RNA SYNTHESIS MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 275. EUROPE, MIDDLE EAST & AFRICA RNA SYNTHESIS MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 276. EUROPE, MIDDLE EAST & AFRICA RNA SYNTHESIS MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 277. EUROPE, MIDDLE EAST & AFRICA RNA SYNTHESIS MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 278. EUROPE, MIDDLE EAST & AFRICA RNA SYNTHESIS MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 279. EUROPE, MIDDLE EAST & AFRICA RNA SYNTHESIS MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 280. EUROPE, MIDDLE EAST & AFRICA RNA SYNTHESIS MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 281. EUROPE, MIDDLE EAST & AFRICA RNA SYNTHESIS MARKET SIZE, BY SCALE, 2018-2024 (USD MILLION)
TABLE 282. EUROPE, MIDDLE EAST & AFRICA RNA SYNTHESIS MARKET SIZE, BY SCALE, 2025-2030 (USD MILLION)
TABLE 283. EUROPE, MIDDLE EAST & AFRICA RNA SYNTHESIS MARKET SIZE, BY COMMERCIAL SCALE, 2018-2024 (USD MILLION)
TABLE 284. EUROPE, MIDDLE EAST & AFRICA RNA SYNTHESIS MARKET SIZE, BY COMMERCIAL SCALE, 2025-2030 (USD MILLION)
TABLE 285. EUROPE, MIDDLE EAST & AFRICA RNA SYNTHESIS MARKET SIZE, BY LABORATORY SCALE, 2018-2024 (USD MILLION)
TABLE 286. EUROPE, MIDDLE EAST & AFRICA RNA SYNTHESIS MARKET SIZE, BY LABORATORY SCALE, 2025-2030 (USD MILLION)
TABLE 287. EUROPE, MIDDLE EAST & AFRICA RNA SYNTHESIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 288. EUROPE, MIDDLE EAST & AFRICA RNA SYNTHESIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 289. EUROPE, MIDDLE EAST & AFRICA RNA SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 290. EUROPE, MIDDLE EAST & AFRICA RNA SYNTHESIS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 291. UNITED KINGDOM RNA SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 292. UNITED KINGDOM RNA SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 293. UNITED KINGDOM RNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 294. UNITED KINGDOM RNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 295. UNITED KINGDOM RNA SYNTHESIS MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 296. UNITED KINGDOM RNA SYNTHESIS MARKET SIZE, BY CHEMICAL SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 297. UNITED KINGDOM RNA SYNTHESIS MARKET SIZE, BY ENZYMATIC SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 298. UNITED KINGDOM RNA SYNTHESIS MARKET SIZE, BY ENZYMATIC SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 299. UNITED KINGDOM RNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 300. UNITED KINGDOM RNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 301. UNITED KINGDOM RNA SYNTHESIS MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 302. UNITED KINGDOM RNA SYNTHESIS MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 303. UNITED KINGDOM RNA SYNTHESIS MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 304. UNITED KINGDOM RNA SYNTHESIS MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 305. UNITED KINGDOM RNA SYNTHESIS MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 306. UNITED KINGDOM RNA SYNTHESIS MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 307. UNITED KINGDOM RNA SYNTHESIS MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 308. UNITED KINGDOM RNA SYNTHESIS MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 309. UNITED KINGDOM RNA SYNTHESIS MARKET SIZE, BY SCALE, 2018-2024 (USD MILLION)
TABLE 310. UNITED KINGDOM RNA SYNTHESIS MARKET SIZE, BY SCALE, 2025-2030 (USD MILLION)
TABLE 311. UNITED KINGDOM RNA SYNTHESIS MARKET SIZE, BY COMMERCIAL SCALE, 2018-2024 (USD MILLION)
TABLE 312. UNITED KINGDOM RNA SYNTHESIS MARKET SIZE, BY COMMERCIAL SCALE, 2025-2030 (USD MILLION)
TABLE 313. UNITED KINGDOM RNA SYNTHESIS MARKET SIZE, BY LABORATORY SCALE, 2018-2024 (USD MILLION)
TABLE 314. UNITED KINGDOM RNA SYNTHESIS MARKET SIZE, BY LABORATORY SCALE, 2025-2030 (USD MILLION)
TABLE 315. UNITED KINGDOM RNA SYNTHESIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 316. UNITED KINGDOM RNA SYNTHESIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 317. GERMANY RNA SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 318. GERMANY RNA SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 319. GERMANY RNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 320. GERMANY RNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 321. GERMANY RNA SYNTHESIS MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 322. GERMANY RNA SYNTHESIS MARKET SIZE, BY CHEMICAL SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 323. GERMANY RNA SYNTHESIS MARKET SIZE, BY ENZYMATIC SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 324. GERMANY RNA SYNTHESIS MARKET SIZE, BY ENZYMATIC SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 325. GERMANY RNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 326. GERMANY RNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 327. GERMANY RNA SYNTHESIS MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 328. GERMANY RNA SYNTHESIS MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 329. GERMANY RNA SYNTHESIS MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 330. GERMANY RNA SYNTHESIS MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 331. GERMANY RNA SYNTHESIS MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 332. GERMANY RNA SYNTHESIS MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 333. GERMANY RNA SYNTHESIS MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 334. GERMANY RNA SYNTHESIS MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 335. GERMANY RNA SYNTHESIS MARKET SIZE, BY SCALE, 2018-2024 (USD MILLION)
TABLE 336. GERMANY RNA SYNTHESIS MARKET SIZE, BY SCALE, 2025-2030 (USD MILLION)
TABLE 337. GERMANY RNA SYNTHESIS MARKET SIZE, BY COMMERCIAL SCALE, 2018-2024 (USD MILLION)
TABLE 338. GERMANY RNA SYNTHESIS MARKET SIZE, BY COMMERCIAL SCALE, 2025-2030 (USD MILLION)
TABLE 339. GERMANY RNA SYNTHESIS MARKET SIZE, BY LABORATORY SCALE, 2018-2024 (USD MILLION)
TABLE 340. GERMANY RNA SYNTHESIS MARKET SIZE, BY LABORATORY SCALE, 2025-2030 (USD MILLION)
TABLE 341. GERMANY RNA SYNTHESIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 342. GERMANY RNA SYNTHESIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 343. FRANCE RNA SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 344. FRANCE RNA SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 345. FRANCE RNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 346. FRANCE RNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 347. FRANCE RNA SYNTHESIS MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 348. FRANCE RNA SYNTHESIS MARKET SIZE, BY CHEMICAL SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 349. FRANCE RNA SYNTHESIS MARKET SIZE, BY ENZYMATIC SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 350. FRANCE RNA SYNTHESIS MARKET SIZE, BY ENZYMATIC SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 351. FRANCE RNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 352. FRANCE RNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 353. FRANCE RNA SYNTHESIS MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 354. FRANCE RNA SYNTHESIS MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 355. FRANCE RNA SYNTHESIS MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 356. FRANCE RNA SYNTHESIS MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 357. FRANCE RNA SYNTHESIS MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 358. FRANCE RNA SYNTHESIS MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this RNA Synthesis market report include:
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Danaher Corporation
  • Agilent Technologies, Inc.
  • Eurofins Scientific SE
  • Azenta, Inc.
  • GenScript Biotech Corporation
  • Bio-Rad Laboratories, Inc.
  • QIAGEN N.V.
  • PerkinElmer, Inc.

Related Reports

mRNA Synthesis & Manufacturing Market by Services (Capping & Tailing, Formulation, in Silico Design), Service Type (Custom mRNA Synthesis, Standard mRNA Production), Manufacturing Process, Manufacturing Scale, Technology, Application, Usage, End-User - Global Forecast 2025-2030 - Product Image

mRNA Synthesis & Manufacturing Market by Services (Capping & Tailing, Formulation, in Silico Design), Service Type (Custom mRNA Synthesis, Standard mRNA Production), Manufacturing Process, Manufacturing Scale, Technology, Application, Usage, End-User - Global Forecast 2025-2030

  • Report
  • 189 Pages
  • Global
From
Automated Oligonucleotide Synthesizer Market by Product Type (Consumables, Instruments, Services), Application (DNA Synthesis, RNA Synthesis, Therapeutic Oligonucleotides), Technology, End User, Scale - Global Forecast 2025-2030 - Product Image

Automated Oligonucleotide Synthesizer Market by Product Type (Consumables, Instruments, Services), Application (DNA Synthesis, RNA Synthesis, Therapeutic Oligonucleotides), Technology, End User, Scale - Global Forecast 2025-2030

  • Report
  • 180 Pages
  • Global
From
Self-amplifying RNA Synthesis Market Size, Share & Trends Analysis Report by Product & Service (Products, Custom Synthesis Services), Application (Therapeutics Development, Biomedical Research) by End Use, Region, with Growth Forecasts, 2025-2030 - Product Image

Self-amplifying RNA Synthesis Market Size, Share & Trends Analysis Report by Product & Service (Products, Custom Synthesis Services), Application (Therapeutics Development, Biomedical Research) by End Use, Region, with Growth Forecasts, 2025-2030

  • Report
  • 120 Pages
  • Global
From
CircRNA Synthesis Market Size, Share & Trends Analysis Report By Product & Service (Reagents & Kits), By Application (Therapeutics Development), By End-use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

CircRNA Synthesis Market Size, Share & Trends Analysis Report By Product & Service (Reagents & Kits), By Application (Therapeutics Development), By End-use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 120 Pages
  • Global
From
mRNA Synthesis Raw Materials - Global Strategic Business Report - Product Image

mRNA Synthesis Raw Materials - Global Strategic Business Report

  • Report
  • 278 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.